Intero Biosystems wants drugmakers to test on mini human intestines, not animals
At a glance
Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand its organoid technology.
- Primary source
- TechCrunch — Read original article
- Published
- Topic
- Technology
Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand its organoid technology.
This summary comes from TechCrunch. Read the full article at the original source.
References
More in Technology
Ricursive Intelligence is betting on AI-designed chips to help solve the compute crisis
The founders detailed how their startup is developing AI that can design chips, learn from each iteration, and improve subsequent designs, all with the goal of automating and…
Flock CEO defends surveillance technology amid national backlash: ‘We shouldn’t pause progress’
At TechCrunch Disrupt, Flock CEO Garrett Langley defended his company's surveillance technology despite growing privacy concerns, arguing that its crime-fighting benefits outweigh…
Meet the five companies competing in the Startup Battlefield finals at Disrupt 2026
It’s time to unveil the five companies that will be competing in the Startup Battlefield finals.
Gudea leverages AI to help organizations prevent social media crises before they erupt
Every day, conversations unfold across social media and websites around the world. A seemingly insignificant post—whether it involves AI-generated misinformation, hate speech, or…